Search

Author/Creator Laurie, S.A.

1. Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7). (February 2017)

Authors:
Hirsh, V.; Park, K.; Tan, E.H.; Zhang, L.; O'Byrne, K.; Boyer, M.; Yang, J.C.H.; Mok, T.; Lee, K.H.; Lu, S.; Shi, Y.; Kim, S.W.; Laskin, J.; Kim, D.W.; Laurie, S.A.; Kölbeck, K.; Fan, J.; Dodd, N.; Märten, A.; Paz-Ares, L.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search